The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical outcomes of patients (pts) age 60 or younger treated with docetaxel (DOC) for castration-resistant prostate cancer (CRPC): Results of an Italian multicenter retrospective study (CYCLOP study).
Antonello Veccia
No relevant relationships to disclose
Cinzia Ortega
No relevant relationships to disclose
Giuseppe di Lorenzo
No relevant relationships to disclose
Francesca La Russa
No relevant relationships to disclose
Salvatore Luca Burgio
No relevant relationships to disclose
Gaetano Facchini
No relevant relationships to disclose
Caterina Messina
No relevant relationships to disclose
Cosimo Sacco
No relevant relationships to disclose
Gilbert Spizzo
No relevant relationships to disclose
Michele Aieta
No relevant relationships to disclose
Michele Lodde
No relevant relationships to disclose
Giovanni Mansueto
No relevant relationships to disclose
Paolo A. Zucali
No relevant relationships to disclose
Alessandro D'Angelo
No relevant relationships to disclose
Roberto Iacovelli
No relevant relationships to disclose
Francesco Massari
No relevant relationships to disclose
Franco Morelli
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose
Fiorella Ruatta
No relevant relationships to disclose
Orazio Caffo
No relevant relationships to disclose